- Home
- PXLW vs DYAI Comparison
PXLW vs DYAI Comparison
Compare PXLW & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- DYAI
- Stock Information
- Founded
- PXLW 1997
- DYAI 1979
- Country
- PXLW United States
- DYAI United States
- Employees
- PXLW N/A
- DYAI N/A
- Industry
- PXLW Semiconductors
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PXLW Technology
- DYAI Health Care
- Exchange
- PXLW Nasdaq
- DYAI Nasdaq
- Market Cap
- PXLW 36.1M
- DYAI 30.2M
- IPO Year
- PXLW 2000
- DYAI 2004
- Fundamental
- Price
- PXLW $6.93
- DYAI $0.96
- Analyst Decision
- PXLW Strong Buy
- DYAI Strong Buy
- Analyst Count
- PXLW 3
- DYAI 1
- Target Price
- PXLW $14.33
- DYAI $3.00
- AVG Volume (30 Days)
- PXLW 124.7K
- DYAI 132.8K
- Earning Date
- PXLW 11-11-2025
- DYAI 11-12-2025
- Dividend Yield
- PXLW N/A
- DYAI N/A
- EPS Growth
- PXLW N/A
- DYAI N/A
- EPS
- PXLW N/A
- DYAI N/A
- Revenue
- PXLW $33,205,000.00
- DYAI $3,342,195.00
- Revenue This Year
- PXLW N/A
- DYAI $18.18
- Revenue Next Year
- PXLW $23.74
- DYAI $87.65
- P/E Ratio
- PXLW N/A
- DYAI N/A
- Revenue Growth
- PXLW N/A
- DYAI N/A
- 52 Week Low
- PXLW $4.67
- DYAI $0.71
- 52 Week High
- PXLW $15.42
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- PXLW 49.01
- DYAI 43.62
- Support Level
- PXLW $5.60
- DYAI $0.90
- Resistance Level
- PXLW $7.20
- DYAI $1.00
- Average True Range (ATR)
- PXLW 0.46
- DYAI 0.09
- MACD
- PXLW 0.24
- DYAI 0.00
- Stochastic Oscillator
- PXLW 79.69
- DYAI 47.50
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.